Baillie Gifford & CO Castle Biosciences Inc Transaction History
Baillie Gifford & CO
- $126 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding CSTL
# of Institutions
172Shares Held
25.5MCall Options Held
511KPut Options Held
130K-
Black Rock Inc. New York, NY3.04MShares$85.5 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT2.33MShares$65.4 Million0.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$44.3 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.5MShares$42.1 Million0.02% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.22MShares$34.2 Million0.44% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $739M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...